SCHEMBL7368797

SCHEMBL7368797

CCOC(=O)C(C(=O)O)c1ccc(OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.50
LDHA P00338 1/20 0.49
ALOX15 P16050 1/20 0.48
AKR1C3 P42330 5/20 0.48
AKR1C2 P52895 5/20 0.48
PTGS1 P23219 3/20 0.48
NPC1 O15118 1/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
PAX8 Q06710 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
AKR1C1 Q04828 1/20 0.48
HPGD P15428 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
GLA P06280 1/20 0.44
KMT2A Q03164 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1043694 0.91 ALOX15 (0.51) MMP8LDHAALOX15NPC1MAPT
SCHEMBL19926010 0.88 MMP8 (0.51) MMP8ALOX15NPC1MAPTRAB9A
SCHEMBL24254586 0.88 RAB9A (0.51) LDHAAKR1C3AKR1C2PTGS1NPC1
SCHEMBL28847555 0.87 LDHA (0.46) LDHAAKR1C3AKR1C2PTGS1NPC1
SCHEMBL28801156 0.87 GRM6 (0.49) MMP8ALOX15NPC1MAPTRAB9A
SCHEMBL2461151 0.87 ALOX15 (0.48) MMP8ALOX15NPC1MAPTRAB9A
SCHEMBL20913026 0.84 ALOX15 (0.46) MMP8ALOX15NPC1MAPTRAB9A
SCHEMBL1451206 0.84 RAB9A (0.57) LDHAAKR1C3AKR1C2PTGS1NPC1
SCHEMBL7093345 0.83 NPC1 (0.56) MMP8NPC1MAPTRAB9APAX8
SCHEMBL1275691 0.82 MMP8 (0.70) MMP8NPC1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022036033-A2 SOLID STATE FORMS OF AN ORGANIC COMPOUND SERVIER PHARMACEUTICALS, LLC (US) 2022-02-17 WO disclosed
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed
EP-0957092-A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions Boehringer Ingelheim Pharma KG (DE) 1999-11-17 EP disclosed
US-5861412-A CARDIOPROTECTIVE AGENTS, CEREBROPROTECTIVE AGENTS, AGENTS FOR TREATING CHRONIC INFLAMMATORY PROCESSES, ANTIPROLIFERATIVE AGENTS AND AS AGENTS FOR TREATING ULCERATIVE COLITIS AND CROHN'S DISEASE BOEHRINGER INGELHEIM KG (DE) 1999-01-19 US disclosed
US-5674878-A ANTIPROLIFERATIVE,-TUMOR AND -CARCINOGENIC AGENTS; ULCERATIVE COLITIS; CROHN*S DISEASE BOEHRINGER INGELHEIM KG (DE) 1997-10-07 US disclosed
US-5643919-A TREATMENT OF CROHN*S DISEASE, ULCERATIVE COLITIS BOEHRINGER INGELHEIM KG (DE) 1997-07-01 US disclosed
EP-0647220-A1 RING-CLOSED DIHYDROPYRIDINES AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) 1995-04-12 EP disclosed
WO-1994000435-A1 RING-CLOSED DIHYDROPYRIDINES AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM KG (DE) 1994-01-06 WO disclosed